2.97

2.62% -0.08

After Hours: 2.97

Sight Sciences Inc (SGHT)

Overview News Price History Option Chain Financials Why SGHT Down? Discussions Forecast

Sight Sciences Inc stock is traded at $2.97, with a volume of 64,002. It is down -2.62% in the last 24 hours and down -15.86% over the past month. Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Previous Close:

$3.05

Open:

$3.09

24h Volume:

64,002

Relative Volume:

0.27

Market Cap:

$149.68M

Revenue:

$81.06M

Net Income/Loss:

$-55.55M

P/E Ratio:

-2.6053

EPS:

-1.14

Net Cash Flow:

$-47.98M

1W Performance:

+0.34%

1M Performance:

-15.86%

6M Performance:

-61.68%

1Y Performance:

-34.00%

1-Day Range:

$2.96

$3.1499

1-Week Range:

$2.86

$3.175

52-Week Range:

$2.675

$8.45

Sight Sciences Inc Stock (SGHT) Company Profile

Name

Sight Sciences Inc

Sector

Healthcare (1174)

Industry

Medical Devices (154)

Phone

(415) 889-0550

Address

4040 CAMPBELL AVE,, MENLO PARK

Employee

214

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

SGHT's Discussions on Twitter

Compare SGHT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SGHT Sight Sciences Inc	2.97	149.68M	81.06M	-55.55M	-47.98M	-1.14
ABT Abbott Laboratories	128.81	223.42B	41.95B	13.40B	6.49B	7.65
BSX Boston Scientific Corp	103.04	151.86B	15.91B	1.79B	1.89B	1.21
SYK Stryker Corp	390.43	148.84B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	91.99	117.96B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	73.22	43.19B	6.60B	4.16B	490.10M	6.93

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-06-24	Initiated	UBS	Buy
Nov-04-24	Downgrade	Lake Street	Buy → Hold
Aug-21-24	Initiated	Lake Street	Buy
Sep-12-23	Downgrade	BofA Securities	Neutral → Underperform
Sep-12-23	Downgrade	Piper Sandler	Overweight → Neutral
Sep-12-23	Downgrade	William Blair	Outperform → Mkt Perform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jul-10-23	Downgrade	Citigroup	Buy → Neutral
Jan-06-23	Upgrade	Stifel	Hold → Buy
Oct-04-22	Initiated	Needham	Hold
Jul-26-22	Initiated	Stifel	Hold
Feb-03-22	Initiated	William Blair	Outperform
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight

View All

Sight Sciences Inc Stock (SGHT) Latest News

Jan 29, 2025

JPMorgan Chase & Co. Acquires 53,658 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

Jan 29, 2025

Sight Sciences executives receive salary increases and bonus targets - Investing.com

Jan 29, 2025

Jan 28, 2025

Sight Sciences Enhances Executive Compensation for 2025 - TipRanks

Jan 28, 2025

Sight Sciences price target lowered to $5 from $5.50 at UBS - MSN

Jan 28, 2025

Sight Sciences (NASDAQ:SGHT) Price Target Cut to $5.00 by Analysts at UBS Group - Defense World

Jan 28, 2025

Jan 27, 2025

UBS Group Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $5.00 - MarketBeat

Jan 27, 2025

Jan 25, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Receives $4.72 Average PT from Analysts - MarketBeat

Jan 25, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jan 25, 2025

Jan 24, 2025

Promising US Penny Stocks To Consider In January 2025 - Simply Wall St

Jan 24, 2025

Have Sight Sciences Insiders Been Selling Stock? - Simply Wall St

Jan 24, 2025

Jan 23, 2025

Long Focus Capital Management, LLC Increases Stake in Sight Scie - GuruFocus.com

Jan 23, 2025

Sight sciences CTO David Badawi sells $15,081 in stock - MSN

Jan 23, 2025

Jan 22, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) CEO Sells $72,471.48 in Stock - MarketBeat

Jan 22, 2025

Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells 6,922 Shares of Stock - MarketBeat

Jan 22, 2025

Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 5,423 Shares of Stock - MarketBeat

Jan 22, 2025

Sight sciences CEO Paul Badawi sells shares worth $72,570 - MSN

Jan 22, 2025

Sight sciences CEO Paul Badawi sells shares worth $72,570 By Investing.com - Investing.com Australia

Jan 22, 2025

Sight sciences chief legal officer sells shares worth $19,250 - MSN

Jan 22, 2025

Sight sciences CTO David Badawi sells $15,081 in stock By Investing.com - Investing.com Australia

Jan 22, 2025

Jan 21, 2025

Sight sciences chief legal officer sells shares worth $19,250 By Investing.com - Investing.com South Africa

Jan 21, 2025

Jan 20, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Shares Bought by Barclays PLC - Defense World

Jan 20, 2025

Jan 19, 2025

Kck Ltd. Invests $15.93 Million in Sight Sciences, Inc. (NASDAQ:SGHT) - MarketBeat

Jan 19, 2025

Jan 17, 2025

Lake Street Capital Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World

Jan 17, 2025

Is Sight Sciences (NASDAQ:SGHT) Using Debt Sensibly? - Simply Wall St

Jan 17, 2025

Jan 15, 2025

Expert Outlook: Sight Sciences Through The Eyes Of 5 Analysts - Benzinga

Jan 15, 2025

Lake Street Capital Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $3.00 - MarketBeat

Jan 15, 2025

Lake Street trims Sight Sciences price target amid Medicare coverage changes - Investing.com Nigeria

Jan 15, 2025